Biotech VC Funds

Heran Partners, founded in 2020 and based in Antwerp, Belgium, is a venture capital firm focusing on MedTech and HealthTech ventures. Their mission is to fuel the growth of innovative technologies at the intersection of life sciences and data. They support startups and scale-ups that develop disruptive innovations ranging from medical devices to AI solutions for diagnostics and patient monitoring. Heran Partners has a strategic investment approach, targeting key drivers in healthcare such as the need for insightful data, cost-effective solutions, and personalized medicine. The fund typically invests up to EUR 5 million in early-stage companies, offering not only financial support but also strategic guidance, scientific expertise, and a strong network to maximize the ventures' potential. Notable investments include companies like Icometrix, which uses AI to quantify brain structures from MR and CT scans, and Hypervision Surgical, an advanced surgical imaging and data analytics platform. The fund has also seen successful exits, including BlueBee and PharmaFluidics. The team is led by experienced professionals like Annie Vereecken, a serial life sciences entrepreneur, Katleen Vandersmissen, Herman Verrelst, and Joris Mortelmans. They emphasize building long-term relationships with their portfolio companies, growing hand-in-hand with founders and management teams. Heran Partners actively co-invests with other venture capital firms to leverage complementary skills and networks, positioning themselves as a key player in the European HealthTech investment landscape​.

Heritas Capital is a Singapore-based private equity and venture capital firm that focuses on high-growth sectors such as healthcare, education, and technology. Established in 1997, the firm has evolved into a key player in impact investing, driven by its philosophy of “Invest with Purpose, Impact Across Generations.” The firm manages a diverse portfolio of investments, backing companies that aim to create positive social and environmental change while delivering sustainable financial returns. Heritas Capital actively supports ventures across Asia through a multi-stage investment platform, targeting seed to growth stages. It has been involved in significant funding rounds for companies like Holmusk, Hummingbird Bioscience, and Cakap, addressing needs in areas such as digital health, biotech, and edtech. The firm also partners with organizations like SEEDS Capital to co-invest in promising startups, helping scale impact-focused innovations. Heritas Capital’s approach includes a strong commitment to improving access to healthcare and lifelong learning while leveraging technology to drive efficiencies in industries like foodtech and urban solutions. By aligning with partners who share their vision, Heritas ensures that their investments have a long-lasting, generational impact.

Heuristic Capital Partners is an early-stage venture capital firm based in Santa Clara, California. Established in 2016, the firm focuses on investments in hardware-centric startups, especially within the health tech, robotics, medtech, and consumer electronics sectors. The firm aims to support companies through critical stages such as prototyping, financing, manufacturing, and scaling up their businesses. Heuristic Capital Partners has made 46 investments, with notable exits including companies like Lucira Health and LARQ. They provide a hands-on approach, leveraging over 25 years of professional and personal venture investment experience from their three managing directors: Michael Liao, Ren Du MD, and Shu Cao. This team brings a wealth of experience from startup challenges to IPOs and mergers. Their investment strategy is rooted in practical problem-solving and creativity, aiming to help startups overcome hurdles and achieve growth. The firm has raised $34 million for their first venture fund, emphasizing their commitment to supporting early-stage hardware innovations​.

HG Ventures, the corporate venture capital arm of The Heritage Group, focuses on innovative solutions in industrial, infrastructure, and environmental sectors. Since its inception in 2018, HG Ventures has invested in transformative technologies and business models, supporting early to growth-stage companies. Notable portfolio companies include ClearFlame Engines, Valerann, and Aclarity, which work on advanced engine technology, smart road infrastructure, and PFAS destruction, respectively. Headquartered in Indianapolis, Indiana, HG Ventures has a global investment reach. Their strategy is deeply integrated with The Heritage Group’s industrial and environmental expertise, allowing them to offer both capital and substantial industry knowledge. HG Ventures actively leads funding rounds, often working closely with entrepreneurs to scale and commercialize technologies. The fund's average check size varies depending on the stage, typically investing substantial amounts to support scaling ventures. The team, led by co-founders John Glushik and Kip Frey, brings extensive experience in venture capital and industrial operations. Entrepreneurs can approach HG Ventures with a strong alignment to their sectors, particularly if they have a scalable solution that fits within HG’s strategic domains. HG Ventures stands out by providing not just financial support but also leveraging their network and technical expertise to help startups navigate growth challenges and market entry​

Highbury Group is an early-stage venture capital firm, founded by Dr. Ling Wong and based in Seattle, Washington. Established in 2014, the firm specializes in investments within the healthcare, biotechnology, digital health, and AI sectors. With a deep focus on transformative technologies, Highbury Group supports innovative companies working in diagnostics, healthcare technology, and AI-driven solutions. The firm seeks out companies at the seed and Series A stages, with typical investments ranging from $500,000 to $50 million, targeting a sweet spot of around $10 million. The firm has built a strong reputation through strategic investments in industry leaders like Notion, ScienceIO, and Spring Discovery, positioning itself at the forefront of the healthcare and biotech spaces. Highbury Group has seen several notable exits, including Guardant Health’s IPO and the acquisition of companies like Edify and Scanwell Health. Dr. Ling Wong brings extensive experience as both an operator and investor, with a proven track record of accelerating growth for portfolio companies. The firm’s investments focus on solving critical healthcare challenges through innovation, aiming to back companies that have the potential to make a significant impact on health outcomes globally. Highbury Group's unique investment strategy combines deep sector expertise with a commitment to supporting early-stage startups through their most critical phases of development. The firm’s approach ensures it plays a pivotal role in shaping the future of healthcare technology and AI​.

Hellman & Friedman (H&F) is a prominent private equity firm with a long history of making large-scale investments in high-quality growth businesses. Founded in 1984, the firm is headquartered in San Francisco, with additional offices in New York and London. H&F focuses on a concentrated investment strategy, deploying significant capital in a limited number of sectors where it has deep expertise, such as software and technology, financial services, healthcare, consumer and retail, and other business services​. The firm recently closed its tenth fund, Hellman & Friedman Capital Partners X (HFCP X), with commitments totaling $24.4 billion, making it one of the largest private equity funds ever raised. This fund will enable H&F to continue its strategy of targeting large-scale investments in outstanding growth businesses, primarily in North America and Europe. H&F is known for its collaborative approach, working closely with management teams to develop and implement value creation plans tailored to each company's specific needs. The firm prides itself on its long-term investment horizon and alignment of interests with its portfolio companies, fostering a culture of mutual success.

Hike Ventures is a venture capital fund specializing in artificial intelligence and machine learning. Founded by seasoned professionals in San Francisco, Tokyo, and Toronto, Hike Ventures focuses on early-stage investments in startups that leverage AI to solve well-defined problems in innovative ways. Their notable investments include companies like Beatdapp, Botpress, CalmWave, and Greeneye, which are driving advancements in sectors ranging from media and entertainment to healthcare and agriculture. The fund primarily invests in North America and Japan, supporting startups that bring transformative AI solutions to market. Their strategy involves not just capital investment but also providing strategic support to help startups scale effectively. Hike Ventures typically invests in seed-stage rounds, offering checks that allow startups to accelerate their growth while benefiting from the fund's deep expertise in AI and machine learning. Key team members include Mikihiro Yasuda, based in San Francisco, who has a robust background in tech leadership and venture investment, and Taka Shoji, based in Tokyo, who has extensive experience in startup incubation and international investment. Both partners bring a wealth of experience from their previous roles in companies like Digital Garage, Netscape, and Baidu Japan. Hike Ventures is proactive in its engagement with startups, often leading rounds and providing hands-on guidance. They value approaches that combine algorithmic innovation with human insight, seeking out startups that can navigate complex AI challenges with practical, scalable solutions.

Hillhouse Investment Group is a leading global investment firm, founded in 2005 by Zhang Lei. Based in Hong Kong with additional offices in Beijing, Hillhouse focuses on long-term investments across public and private markets. The firm’s strategy revolves around building sustainable, high-quality businesses, with particular emphasis on healthcare, consumer, industrials, and technology sectors. Initially starting with a $20 million investment from Yale University's endowment fund, Hillhouse has grown into a financial giant managing over $60 billion in assets. Known for its rigorous research and hands-on approach, the firm partners with management teams to drive innovation and growth in its portfolio companies. Notable investments include major players like Tencent, Zoom, and JD.com. Hillhouse is also active in private equity and venture capital, making significant contributions to early and growth-stage companies across Asia, North America, and Europe. Its venture arm, GL Ventures, supports early-stage technology and healthcare startups. The firm is recognized for its ability to anticipate market trends and build long-term value in companies that can withstand evolving economic landscapes. With a reputation for aligning closely with management teams and maintaining a disciplined investment strategy, Hillhouse continues to be a powerful force in global markets.

Hiventures, a Hungarian state-owned venture capital fund, is renowned for its extensive portfolio and dynamic investment strategy. With a focus on supporting startups from pre-seed to growth stages, Hiventures has made over 770 investments across various sectors, including software services, cloud computing, and cybersecurity. Notable investments include Access4you, iBar Experience, and Surviot Monitoring, showcasing their commitment to innovation in diverse industries. Geographically, Hiventures primarily invests within Hungary, emphasizing the growth of the local entrepreneurial ecosystem. Their strategy involves flexible investment conditions and a quick adaptation to the needs of startups, making them a preferred partner for early-stage ventures. Hiventures typically invests around $983,000 per round, actively leading many of these investments. They maintain a high engagement level, with an average of 30.96 rounds per year, peaking in 2021. The fund's team, including key figures like CEO Eszter Jandrasics and Senior Investment Manager Ádám Horváth, brings deep expertise in venture capital and business development. For startups looking to approach Hiventures, it's beneficial to highlight innovative solutions and scalability. They prefer well-prepared pitches that align with their focus on fostering technological advancements and economic growth in Hungary.

Hong Kong Science and Technology Parks Corporation (HKSTP) is the leading innovation and technology (I&T) ecosystem in Hong Kong. Established in 2001, HKSTP fosters tech startups and industry growth, focusing on sectors like healthtech, AI and robotics, fintech, and smart city innovations. The corporation manages a network that includes the Hong Kong Science Park, InnoCentre, and InnoParks, supporting over 1,700 companies and 14,000 R&D professionals. HKSTP offers full-cycle support to startups, from incubation and prototyping to funding and commercialization. They manage the HKSTP Venture Fund, a HK$1 billion asset fund, to support high-growth tech ventures, and have groomed multiple unicorns within their ecosystem. With strong connections to the Greater Bay Area, HKSTP also helps companies expand into mainland China. Their resources include world-class R&D labs, co-working spaces, advanced manufacturing centers, and a broad investor network. HKSTP’s mission is to drive collaboration, accelerate innovation, and cultivate talent for Hong Kong and the broader region, positioning the city as a leading global innovation hub.

HLM Venture Partners is a leading venture capital firm focused exclusively on healthcare technology and services. Based in Waltham, Massachusetts, the firm has been at the forefront of healthcare investment for over 40 years, deploying more than $400 million across 100+ companies. HLM targets companies that are capital-efficient and patient-centric, helping them scale by offering not just financial support, but strategic guidance and deep industry expertise. The firm focuses on key healthcare sectors like healthcare IT, value-based care, medical devices, and patient engagement. HLM is particularly interested in companies addressing critical issues like expanding access to care, behavioral health innovations, and solutions for provider shortages. Notable investments include Teladoc, a pioneer in telemedicine, NeuroFlow, which leverages AI for mental health support, and mPulse Mobile, a leader in mobile patient engagement solutions​. HLM prides itself on being a first-call partner for its portfolio companies, providing hands-on support to help them navigate complex regulatory landscapes and reach their growth potential. Their extensive healthcare network gives their startups unrivaled access to key decision-makers across the care continuum. Over the years, HLM has created significant value for both its portfolio companies and investors, facilitating the growth of several iconic healthcare brands. By aligning themselves with bold, principled management teams, HLM continues to drive transformative healthcare solutions that improve both quality and cost of car.

HOF Capital is a global venture capital firm headquartered in New York, focused on investing in transformative technology companies from idea to IPO. With support from over 70 influential family offices, global corporations, and institutions, HOF provides startups with more than just capital—they offer strategic partnerships that open doors to new markets, customer bases, and operational growth. Their portfolio features industry-leading companies such as Alibaba, Epic Games, UiPath, and ASAPP. HOF Capital specializes in sectors like fintech, deep tech, healthcare, and logistics, making investments from pre-seed to late-stage rounds. The firm’s approach emphasizes long-term value creation, guiding entrepreneurs through various growth stages with business development, sales, and fundraising support. With offices in New York, London, and San Francisco, and a team of investors spread across key global regions, HOF operates as a bridge between startups and large-scale enterprises. Co-founded by Hisham Elhaddad, Onsi Sawiris, and Fady Yacoub, HOF leverages its vast network of partners, including industry giants like Visa, Nvidia, and Daimler, to provide startups with critical resources and strategic advice. Their multi-stage investment strategy, combined with deep industry knowledge and a vast network, helps startups scale quickly while navigating complex challenges in highly competitive environments.

Homebrew is a unique venture capital fund dedicated to early-stage investments, founded by Hunter Walk and Satya Patel. With a focus on seed-stage startups, Homebrew partners with mission-driven founders to build transformative companies. They have a notable portfolio including companies like Plaid, Mercury, and Winnie, reflecting their commitment to impactful ventures. Primarily investing in software and technology sectors, Homebrew targets industries like fintech, AI, robotics, and healthcare. Their geographic focus is predominantly in North America, supporting startups across the U.S. and Canada. Homebrew's investment strategy emphasizes a hands-on approach. They typically lead or co-lead seed rounds, with initial investments ranging from $250k to $800k. Homebrew is known for their deep involvement with portfolio companies, offering not just capital but also strategic counsel, operational support, and access to their extensive network. Recently, Homebrew transitioned to an evergreen investment model, utilizing their own capital to maintain flexibility and alignment with founders' needs. This shift allows them to engage with startups at various stages without being constrained by traditional fund structures. The team at Homebrew includes industry veterans like Hunter Walk and Satya Patel, both former Google product executives. They are based in Burlingame, California, and are recognized for their commitment to fostering strong, supportive relationships with entrepreneurs.

Honeywell is a global technology and manufacturing leader, delivering a diverse range of products and services across various sectors. In aerospace, Honeywell provides advanced avionics, propulsion, and aircraft management systems, enhancing safety and efficiency for commercial and defense aircraft. Their building technologies division offers smart solutions for energy efficiency, security, and automation, contributing to more sustainable and connected buildings. In the realm of performance materials and technologies, Honeywell develops high-performance chemicals, materials, and industrial software, supporting a wide array of industries from oil and gas to pharmaceuticals. The safety and productivity solutions division focuses on providing innovative safety equipment, advanced software, and workflow automation technologies that boost operational efficiency and worker safety. Honeywell is deeply committed to sustainability, integrating environmental considerations into their product development and operational strategies. They aim to reduce their carbon footprint and help customers achieve their sustainability goals through cutting-edge technologies and solutions. Through continuous innovation, strategic partnerships, and a strong emphasis on quality and reliability, Honeywell strives to drive progress and create value for customers worldwide, shaping a more efficient, safe, and sustainable future.

Horizons Ventures, established in 1999 and headquartered in Hong Kong, is a prominent venture capital firm that focuses on disruptive technology investments. The firm, backed by billionaire Li Ka-shing, has an impressive portfolio that includes companies across various sectors such as AI, biotechnology, fintech, and consumer technology. Notable investments include Zoom, Slack, and Spotify. Horizons Ventures also invested early in DeepMind, which was later acquired by Google, and plant-based meat company Impossible Foods​​. The firm's strategy involves supporting innovative technologies that can drive significant societal impact, from healthcare advancements to environmental sustainability. Horizons Ventures typically invests in early-stage companies but also participates in later-stage rounds. Their approach is to provide not just capital, but also strategic guidance and access to a vast network, helping portfolio companies scale effectively. With over 200 companies in its portfolio and 16 unicorns, Horizons Ventures has a proven track record of identifying and nurturing high-potential startups. The firm operates globally, with significant investments in the U.S., Europe, and Asia, reflecting its international reach and influence​. For startups seeking investment from Horizons Ventures, it is crucial to demonstrate breakthrough technology and substantial growth potential. Engaging with Horizons Ventures can provide access to a robust support system, from strategic advice to market expansion opportunities.

Hoxton Ventures is a London-based early-stage venture capital firm known for backing some of Europe’s most successful startups, including Deliveroo, Babylon Health, and Darktrace. Founded in 2013, Hoxton focuses on investing in disruptive technology companies with the potential to become global leaders in their sectors. The firm primarily targets startups at the pre-seed and seed stages, helping them scale with both financial support and strategic guidance. Hoxton Ventures has a strong track record of identifying innovative companies across diverse industries such as fintech, healthcare, AI, and enterprise software. Their portfolio includes notable investments that have either gone public or reached unicorn status. The firm operates as a partner-only team, ensuring that founders receive direct attention and mentorship from experienced investors who have backgrounds in building and scaling companies themselves. With a proactive approach, Hoxton leverages deep industry expertise and a global network to support the growth of its portfolio companies. The firm typically invests above €3 million and provides operational support to help startups navigate their early stages, positioning them for long-term success in the competitive European startup ecosystem.

High-Tech Gründerfonds (HTGF) is a prominent seed investor based in Bonn, Germany, focused on supporting innovative technology startups in fields such as digital technology, industrial tech, life sciences, and chemistry. Established in 2005, HTGF has invested in over 750 startups and manages more than €2 billion across multiple funds. The firm is a key player in the European venture capital scene, specializing in early-stage investments and follow-on financing. HTGF's approach involves providing more than just capital; they actively assist startups through their vast network, supporting business growth, customer acquisition, and strategic partnerships. The typical investment size starts at €800,000 for seed rounds, with potential follow-on investments of up to €4 million per startup over the company's lifecycle. HTGF has been instrumental in facilitating exits, with over 180 successful exits to date, including IPOs. With the launch of their fourth fund in 2023, HTGF raised nearly €500 million, marking it as their largest fund yet. The firm supports startups not only in Germany but across Europe, as long as they maintain a German presence, helping young companies scale and thrive on the global stage.

Human Capital is a unique venture capital firm based in San Francisco that combines traditional VC investing with a strong focus on talent acquisition and organizational development. Founded by Armaan Ali and Chris Zhang, the firm has a multi-stage investment strategy that spans from seed to growth stages, with a mission to support ambitious founders in building transformative companies. Human Capital has a diverse portfolio, investing in high-potential startups across various sectors, including technology, healthcare, and fintech. Some notable investments include Snowflake, Brex, Livongo, Anduril, and Applied Intuition. The firm emphasizes partnering with founders to build strong teams and scalable businesses, leveraging its extensive network and expertise in recruitment to help companies grow from inception to maturity​/ The firm's approach involves not just capital investment but also providing hands-on support in talent management. They assist portfolio companies in attracting, hiring, and retaining top talent, ensuring that the startups have the human capital necessary to succeed in highly competitive markets​.

Human Ventures is an early-stage venture fund and startup studio based in New York City. They focus on investing in companies that address fundamental human needs across various sectors, such as health and wellness, the future of work and money, and media and attention. Founded on the principle of "human first," Human Ventures supports founders who are passionate about creating products and services that have a meaningful impact on society. The firm is led by a diverse team of experienced professionals, including General Partner and CEO Heather Hartnett, Executive Chairman Joe Marchese, and General Partner and COO Michael Letta. They emphasize values such as growth, resilience, collaboration, and gratitude, which guide their approach to building and supporting companies. Human Ventures' portfolio includes innovative companies like Headspace, an app for meditation and sleep; Paloma Health, an online medical practice for hypothyroidism; and Tiny Organics, a nutrition company for early childhood. The firm also operates "Humans in the Wild," a program that fosters a community of entrepreneurs and provides resources to help them grow and succeed.

Humboldt Fund, founded in 2020 and based in New York, is a venture capital firm focused on investing in the biotech revolution. The fund specializes in early-stage investments in synthetic biology, targeting industries that are transforming the way chemicals, materials, foods, and medicines are made. Humboldt’s mission is to back pioneers in engineering, physical sciences, and life sciences, supporting groundbreaking technologies with the potential to disrupt global markets and solve critical challenges. Key areas of investment include foodtech, healthcare, energy, and advanced materials, with a strong emphasis on synthetic biology and bio-manufacturing. Notable portfolio companies include Metagenomi, Debut Biotech, and Finless Foods, all of which are at the forefront of biotechnological innovation. Humboldt aims to create both economic value and global impact by fostering these revolutionary technologies. Humboldt primarily invests in pre-seed, seed, and Series A stages, with a typical check size ranging from $4M to $36M. The fund is known for supporting companies that contribute to sustainability and technological advancements. By identifying and nurturing trailblazing companies, Humboldt Fund helps bring emerging biotech enterprises to global markets, positioning itself as a key player in the future of biotechnological innovation.

Hummingbird VC, founded in 2010 and based in Antwerp, Belgium, is an early-stage venture capital firm that invests globally, backing founders with groundbreaking ideas. The firm has a strong portfolio with notable investments in companies like Deliveroo, Kraken, and Peak Games. Hummingbird VC focuses on a wide array of industries including fintech, biotech, deep tech, healthcare, and marketplaces, with investments across North America, EMEA, and APAC regions. Hummingbird's investment strategy centers on partnering early with outlier founders and providing unwavering support through the company's lifecycle. They are known for their high conviction and willingness to make substantial investments, often leading funding rounds with check sizes ranging from $500K to over $50M. They prefer a low-friction partnership approach, allowing entrepreneurs to dictate the level of involvement and support needed. Key figures in the team include Barend Van den Brande, the founder, who is based in Belgium, and other partners spread across their international offices. Hummingbird is noted for its patient capital and long-term support, especially during challenging times for startups. They emphasize radical candor and dedication to the founders they back, aiming to foster transformative growth and industry disruption.

Hunniwell Lake Ventures is a Palo Alto-based venture capital firm founded in 2019, specializing in the healthcare sector, with a particular focus on medical devices. The firm targets early-stage companies that innovate in areas such as surgical robotics, electrosurgical technologies, and disease detection systems. Their investment strategy emphasizes reducing technology and regulatory risks by backing innovations that build upon proven technologies. The firm also leverages a global network of suppliers, distributors, and hospital partnerships to help startups scale rapidly and achieve market penetration. Hunniwell typically invests in startups with existing sales teams and distribution channels, aiming to accelerate their growth through strategic partnerships, especially in China, and by sharing infrastructure and expertise. Their portfolio includes notable companies like WaveClear Vascular and CoapTech. Key figures at Hunniwell include Richard Fang and Daniel Teo, both managing partners with extensive backgrounds in medical technology investments. They are supported by industry veterans like John Ashley, an Entrepreneur-in-Residence, who has a track record of leading multiple successful exits in the medtech space.

Huron River Ventures, founded in 2010 and based in Ann Arbor, Michigan, focuses on early-stage investments in agriculture, energy, and manufacturing technology. They primarily invest in the Midwest, supporting startups that offer innovative and sustainable solutions within these sectors. The firm typically invests $1-5 million per company across seed, Series A, and Series B stages. Notable investments include companies like Postmates, SkySpecs, and FarmLogs. Huron River Ventures has a strong track record, having made 50 investments and achieved 16 successful exits. The leadership team, including co-founders Ryan Waddington and Tim Streit, brings extensive experience in technology investments. The firm emphasizes supporting entrepreneurs with both capital and strategic guidance, leveraging their industry knowledge and networks to help startups grow and succeed.

HV Capital, formerly known as Holtzbrinck Ventures, is one of Europe’s most prominent venture capital firms, founded in 2000. With over €2.8 billion in assets under management, HV Capital has backed more than 225 startups, including major European success stories like Zalando, HelloFresh, SumUp, and Flixbus. The firm is known for its long-term commitment to founders, often supporting companies from seed stages through to growth and even exit phases. HV Capital recently launched its largest fund, Fund IX, at €710 million, aimed at startups across various stages from seed to Series D. The fund focuses on industries such as B2B software, consumer tech, healthcare, AI, and logistics. It also emphasizes sustainability, with a portion of the fund allocated to ESG-compliant companies and targets for female leadership across its portfolio. The firm’s investment approach combines financial backing with operational support, fostering an ecosystem where companies can thrive across Europe. HV Capital's team, based in Munich and Berlin, works closely with founders to help scale their businesses internationally.

Hyperplane Venture Capital, founded in 2014 and based in Boston, Massachusetts, focuses on early-stage investments in technology sectors like machine intelligence, AI, distributed systems, automation, cloud computing, and robotics. The firm has a robust portfolio of 112 investments, supporting innovative startups that leverage advanced technologies to solve complex problems. Notable investments include Modulate, Butlr, Flexpa, and LinkSquares. These companies span diverse industries, from AI and machine learning to health tech and enterprise software. Hyperplane has a strong track record with several successful exits, including Aryeo and RoadBotics, and continues to invest in cutting-edge technologies​. The team at Hyperplane includes experienced professionals like Brendan Kohler, John Murphy, and Vivjan Myrto, who bring a wealth of expertise in technology and venture capital. They provide strategic guidance and mentorship to their portfolio companies, helping them navigate growth challenges and scale effectively. Hyperplane's investments are primarily concentrated in the United States, but they also have a presence in other countries, including Canada and the United Kingdom. Their approach involves close collaboration with founders, aiming to drive innovation and create significant market impact through their strategic investments.

Hyphen Capital is a venture capital fund focused on supporting Asian American and Pacific Islander (AAPI) founders. Based in San Francisco, Hyphen Capital actively invests across various stages, with a significant presence in seed and early-stage funding rounds. The fund emphasizes sectors like fintech, enterprise applications, healthcare, and consumer products. Notable investments include Persona, an identity verification solutions provider valued at $1.5 billion, and Prime Roots, a producer of alternative protein products. Other key investments include Super, an online travel booking platform, and Poised, an AI-enabled communication assistant. Hyphen Capital's investment strategy centers on leveraging its strong network of AAPI entrepreneurs and executives, including prominent figures like Kevin Chou (Kabam), Ellen Chen (Mendocino Farms), and Patrick Lee (Rotten Tomatoes). The fund aims to back founders who are poised to disrupt their industries with innovative solutions and significant growth potential. Hyphen Capital tends to lead investment rounds, with typical check sizes ranging from $100,000 to $4.5 million. They prefer startups to approach them with a clear, scalable business model and a strong founding team. The fund has made 38 investments to date, with 3 successful exits. Led by Dave Lu, a well-respected figure in Silicon Valley, Hyphen Capital provides not just capital but also strategic guidance and access to a vast network of industry leaders, making it an invaluable partner for startups looking to scale rapidly. Hyphen Capital's approach is holistic, emphasizing long-term relationships and community support, reflecting their mission to empower the next generation of AAPI founders to achieve extraordinary success.

I2BF Global Ventures, established in 2005, is a venture capital firm focused on early-stage technology investments across various sectors such as clean technology, biotech, IT, and space technology. The firm operates globally, with investments in the United States, Europe, Israel, and other regions. I2BF manages over $400 million in assets and has backed more than 200 entrepreneurs, creating substantial value and numerous high-tech jobs. Their diverse portfolio includes companies like FuboTV, which went public on the NYSE in 2020; General Fusion, a developer of fusion energy technology; and ServiceTitan, a business management software provider for home service companies. Other notable investments include Inbox Health, Odeko, and Peek. I2BF Global Ventures has also seen several successful exits, such as the acquisition of Fieldbit by Help Lightning and the IPO of Presto on NASDAQ. They have a strong focus on identifying and supporting disruptive innovations that bridge the gap between the physical and digital worlds.

IA Ventures, founded in 2010 and based in New York City, focuses on seed and early-stage investments, particularly in the fintech sector. The firm has made 184 investments and has seen 44 exits, showcasing its strong presence and success in the venture capital space. Notable companies in IA Ventures' portfolio include DigitalOcean, a cloud infrastructure provider; The Trade Desk, a global technology company for advertisers; and Datadog, a monitoring and security platform for cloud applications. Other significant investments are in companies like Octane, a fintech company for powersports financing, and YipitData, which provides data-driven research to institutional investors. IA Ventures invests across a variety of sectors including big data and analytics, cybersecurity, AI and machine learning, and SaaS. The firm is known for its hands-on approach, working closely with startups to help them grow and succeed in competitive markets. The team at IA Ventures includes experienced partners like Brad Gillespie and Jesse Beyroutey, who bring extensive expertise and support to their portfolio companies.

IBB Ventures is a prominent venture capital firm based in Berlin, specializing in early-stage investments. Since 1997, it has played a key role in fostering the growth of innovative startups, particularly those based in the Berlin region. With a focus on sectors like software, healthcare, industrial technologies, and creative industries, IBB Ventures supports scalable, disruptive business models that drive innovation. Their investment funds are primarily backed by the Investitionsbank Berlin and the European Regional Development Fund. The firm manages several VC funds, including the VC Fonds Technologie III and the VC Fonds Kreativwirtschaft III, with a total volume of €120 million. In 2022, IBB Ventures introduced an additional €30 million Impact VC Fund to support startups focused on ecological, social, and sustainable goals. Typically, they provide seed and Series A financing, working closely with portfolio companies to achieve sustainable growth and mid-term exits, often through trade sales or IPOs. IBB Ventures has invested in over 260 companies and continues to be a significant player in Berlin's startup ecosystem.

Ibex Investors, established in 2003 and headquartered in Denver, Colorado, is a venture capital firm that invests across various stages of a company's lifecycle, from seed to IPO and beyond. The firm focuses on geographic regions, particularly Israel, and thematic areas such as mobility. Ibex has made notable investments in companies like WEKA, Honeycomb Insurance, and Chemix, demonstrating a strong presence in sectors like IT consulting, property and casualty insurance, and business productivity software. The firm has completed 82 investments and achieved 22 exits, including prominent companies like Cynet, Cobwebs Technologies, and Zimperium. Led by founder and CEO Justin Borus, Ibex Investors aims to provide a world-class experience and value-added support to its portfolio companies, emphasizing a proactive search for overlooked market opportunities. The team includes key partners such as Aaron Rinberg and Gal Gitter, who focus on Israeli investments, highlighting the firm’s strong ties to the Israeli tech ecosystem.

IBM is a global leader in technology, known for its advancements in hybrid cloud solutions, artificial intelligence (AI), and consulting services. The company operates in over 175 countries, serving industries like finance, healthcare, and telecommunications by helping organizations transform their digital infrastructures. One of its key innovations includes the IBM Watson AI platform, which powers everything from generative AI in business to sports analytics, like enhancing ESPN’s fantasy football platform. IBM is also a pioneer in quantum computing and semiconductors, consistently pushing the boundaries of modern technology with breakthroughs like the world’s first 2-nanometer chip in 2021. Their hybrid cloud ecosystem, supported by Red Hat OpenShift, provides companies with flexible and scalable solutions for managing critical operations efficiently and securely. In addition to its technological leadership, IBM is heavily invested in social impact, with initiatives like the IBM SkillsBuild program, offering free training in tech skills to underserved communities. The company is also committed to achieving net-zero carbon emissions by 2030, integrating sustainability into its business operations globally.

Icebreaker.vc, established in 2016 and based in Helsinki, focuses on early-stage investments, particularly in Finland, Sweden, and Estonia. They target pre-seed and seed-stage companies with investments ranging from €150,000 to €800,000. Icebreaker.vc's portfolio includes notable companies such as Valpas, Lumoa, Workfellow, and Oterlu. Icebreaker.vc supports teams with deep domain expertise and a vision for global impact, spanning various sectors like fintech, healthcare, consumer goods, and energy. They emphasize strong, complementary founding teams and provide extensive support through their community of over 1,000 experienced professionals. The firm has raised significant funds to continue backing innovative startups, including a recent €120 million fund to further invest in and support their portfolio companies from the earliest stages. Key team members include Lasse Lehtinen, Aleksi Partanen, and Riku Seppälä, all of whom bring extensive experience in founding and scaling tech companies. Their approach combines capital with strategic operational support to help startups navigate growth challenges and achieve market success.

ICONIQ Capital, a multifaceted investment management firm headquartered in San Francisco, manages over $80 billion in assets. The firm is known for serving influential families and organizations, particularly those in technology, high finance, and entertainment sectors. ICONIQ has a robust portfolio featuring investments in prominent tech companies. Notable portfolio companies include Airbnb, Alibaba, Facebook, Snowflake, and Uber. They also have significant stakes in innovative firms like OpenAI, HashiCorp, and Miro, showcasing their focus on transformative technologies and scalable business models. Their investment strategy involves partnering with inspired entrepreneurs to drive industry transformation. ICONIQ Capital provides not only financial support but also strategic guidance, leveraging their extensive network to foster growth and innovation. The firm operates globally with offices in New York, London, and Hong Kong, offering a comprehensive range of services including private equity, venture capital, real estate, and philanthropic advisory. ICONIQ's team comprises experienced professionals like Divesh Makan, one of the founders, who bring deep expertise and a hands-on approach to managing investments and advising clients.

Icos Capital is a Dutch venture capital firm specializing in ClimateTech investments, focusing on sectors such as food systems, decarbonization, sustainable chemicals, and materials. Since its founding in 2005, Icos Capital has been committed to supporting early-growth stage companies that drive sustainability and industrial decarbonization. The firm is known for its Collaborative Venturing Platform (CVP), which connects startups with leading corporations, providing not only capital but also engineering expertise, market access, and production infrastructure. With a goal to reduce or avoid 1 gigaton of CO2 emissions by 2050, Icos Capital takes a hands-on approach to investing, helping innovative startups scale quickly while ensuring measurable environmental impact. Some of its successful portfolio companies include Carbon Clean, eAgronom, and Holiferm, each making strides in carbon capture, regenerative agriculture, and sustainable product developmen. Icos Capital continues to manage multiple funds, the latest being Icos IV, with a targeted size of €100 million, designed to accelerate sustainability across industries. The firm primarily focuses on European companies but also supports those in the U.S. and Asia with strong ties to the European market.

Idinvest Partners, founded in 1997 and headquartered in Paris, France, is a leading European private equity and venture capital firm. The firm specializes in low and middle-market segments, investing across various stages, including early-stage, growth-stage, and later-stage companies. Idinvest Partners is particularly active in the IT, healthcare, and financial services sectors, and has made notable investments in companies such as Deezer, Criteo, Dailymotion, and Sigfox​. In 2018, Idinvest Partners was acquired by Eurazeo, creating a combined entity with over $15 billion in assets under management. This acquisition has bolstered Idinvest’s capacity to support innovative startups and expand its reach globally​. The firm has a diversified investment strategy, leveraging its expertise in venture and growth capital, private debt, and private equity to drive growth and value creation in its portfolio companies. Idinvest Partners operates with a strong presence in Europe and has extended its investments to the United States and Asia. Recent investments include companies like Dark (aerospace and defense) and Cove (real estate services), highlighting its broad investment approach across different sectors​.

IDIA Capital Investissement is a venture capital and private equity firm based in Montrouge, France. It operates as the investment arm of the Crédit Agricole Group, focusing on minority equity investments to support the growth and development of mid-sized companies (ETIs) and small to medium-sized enterprises (SMEs). Established over 30 years ago, IDIA specializes in sectors such as agribusiness, viticulture, healthcare, tourism, and energy transition​. The firm manages a substantial portfolio with assets under management totaling €2.2 billion. They typically invest between €1 million and €50 million per transaction, leveraging the extensive Crédit Agricole network to provide strategic and financial support to their portfolio companies. IDIA Capital Investissement is committed to responsible investing, emphasizing environmental, social, and governance (ESG) criteria in their decision-making process. This approach aligns with Crédit Agricole's broader mission of promoting sustainable finance and supporting projects that address key societal and environmental challenges​.

iGan Partners is a leading venture capital firm based in Toronto, Canada, specializing in early-stage investments in technology and healthcare sectors. Founded in 1999, iGan Partners has built a strong portfolio by partnering with innovative startups and helping them scale their disruptive technologies. The firm has a diverse portfolio that includes companies like Think Research, a provider of clinical content and technology solutions; MolecuLight, which develops imaging devices for wound care; and eSight, known for creating electronic glasses that improve vision for the legally blind. Other notable investments include MedChart, a platform that enables businesses to access and exchange patient-authorized digital health information, and Cosm Medical, which designs medical devices for personalized pelvic health solutions. iGan Partners typically invests in seed and Series A rounds, with a focus on companies in the healthcare sector, including medical devices, digital health, and health IT. They have been involved in funding rounds for companies like Hyivy Health and Curv Health, supporting innovative solutions in personal health and wellness. The firm is led by a team of experienced professionals, including Founder and Managing Partner Sam Ifergan and Chief Medical Officer Dr. Lorena Tora. Their extensive expertise in healthcare and technology enables them to provide valuable support and strategic guidance to their portfolio companies​.

iGlobe Partners, founded in 1999 and headquartered in Singapore, is a prominent venture capital firm with a global investment strategy. The firm focuses on early to growth-stage investments in tech-driven sectors such as smart cities, synthetic biology, and fintech. iGlobe Partners has a strong track record of investing in transformative companies and has managed funds exceeding USD 500 million​. Their diverse portfolio includes notable companies such as Matterport, which provides AI-powered 3D data platforms to create digital twins of physical spaces, and NerdWallet, a popular personal finance company. Additionally, they have invested in C2i Genomics, a leader in cloud-based cancer diagnostics, and Twist Bioscience, which is revolutionizing DNA synthesis. iGlobe Partners' investment approach emphasizes collaboration with top-tier scientific and entrepreneurial talent to drive innovation. The firm has been instrumental in scaling game-changing companies across the U.S., Europe, and Asia, leveraging its extensive global network to support portfolio companies in expanding their market reach​. With the recent close of their USD 100 million iGlobe Platinum Fund III, the firm continues to invest in high-growth areas, particularly focusing on innovations in healthcare, logistics, and smart city technologies. This strategic focus aims to capitalize on the accelerated adoption of technology driven by the COVID-19 pandemic, promising substantial returns in the long term.

Illinois Ventures is a venture capital firm dedicated to investing in early-stage technology and healthcare companies. Based in Champaign, Illinois, and closely affiliated with the University of Illinois System, the firm focuses on translating innovative research into impactful businesses. Illinois Ventures has a robust portfolio that includes companies like Ocient, a big data analytics company, and EarthSense, a developer of autonomous robots for agriculture. Their investments span various sectors including biotechnology, healthcare IT, clean energy, and advanced manufacturing technologies. The firm primarily invests at the seed and Series A stages, leveraging its strong connections with the University of Illinois to gain early access to groundbreaking technologies. This relationship allows Illinois Ventures to support startups with both capital and strategic guidance, fostering growth from the ground up. The leadership team includes Nancy Sullivan, the CEO and Managing Director, and other experienced professionals like Thomas Parkinson and Nancy Harvey. They bring a wealth of experience in venture capital, business development, and operations, providing comprehensive support to their portfolio companies.

Illumina Ventures is an influential venture capital firm focused on advancing genomics and precision health. Established in partnership with Illumina, the firm targets early-stage companies driving innovation in life science tools, therapeutics, diagnostics, and personal wellness. Their notable investments include leading companies like 23andMe, Twist Bioscience, and Sherlock Biosciences. Illumina Ventures primarily operates within North America but maintains a global investment scope. The firm typically leads investment rounds, with a strong emphasis on startups harnessing cutting-edge technologies like AI, machine learning, and synthetic biology to improve human health. Recent investments highlight their commitment to transformative technologies, with companies such as Actym Therapeutics and Redshift Bio joining their portfolio. Key figures at Illumina Ventures include founding partner Nick Naclerio, who brings extensive experience from his tenure at Illumina Inc., and Malek Faham, promoted to Chief Scientist. The team is complemented by experts like Thomas Ybert of DNA Script, underscoring the firm's robust support for its portfolio companies.

Imaginary Ventures, co-founded by Natalie Massenet and Nick Brown in 2017, is a venture capital firm that focuses on investing in iconic, generationally defining consumer brands and the technology businesses that support them. The firm primarily targets early-stage investments but also participates in late-stage opportunities when they align with their expertise and network. Their portfolio includes well-known companies such as Glossier, Skims, and Daily Harvest, which have become leaders in their respective markets. Other notable investments include Farfetch, Everlane, and Kosas. Imaginary Ventures is known for backing brands that innovate within retail, health, wellness, beauty, and consumer packaged goods sectors. Imaginary Ventures has raised significant funds, with their third fund reaching $500 million, bringing their total assets under management to over $1 billion. This capital allows them to support both early and late-stage companies, ensuring they have the resources to scale effectively. The firm leverages its deep industry knowledge and extensive network to help its portfolio companies navigate the challenges of the modern consumer landscape, particularly in a digital-first world where direct-to-consumer models are increasingly prevalent.

Imec.xpand is a venture capital firm based in Leuven, Belgium, founded in 2017. The firm focuses on early-stage investments in deep-tech innovations, particularly those based on nanoelectronics. Their investment areas span health, agtech, and semiconductor technology, aiming to foster significant technological advancements and growth. Notable investments include PsiQuantum, a quantum computing company, and Axelera AI, a startup developing AI applications for edge computing. Other prominent portfolio companies are Spectricity, which specializes in hyperspectral sensing solutions, and Optalysys, an AI-driven big data and machine learning company. Imec.xpand typically leads funding rounds, with investment amounts averaging around $21 million per round. The firm has made 41 investments to date, with a robust global presence, investing in companies from the U.S., Europe, and beyond. Their strategic approach leverages their affiliation with Imec, a world-renowned R&D hub for nanoelectronics and digital technologies, providing startups with unparalleled access to cutting-edge research, expertise, and infrastructure​. Key team members include Tom Vanhoutte and Frank Bulens, who bring extensive experience in deep tech and venture capital, further solidifying Imec.xpand’s position as a leader in the tech investment space​.

IMO Ventures is a venture capital firm focusing on early-stage investments in technology, media, telecommunications (TMT), fintech, consumer, and healthcare industries. The firm is driven by a mission to support entrepreneurship and innovation, leveraging the extensive experience of its partners who were former tech entrepreneurs and industry leaders. The team at IMO Ventures includes Hai Liu, who has a background in electronic engineering and an MBA from MIT Sloan. He has previously worked with GSR Ventures and Samsung Mobile, bringing significant expertise to the firm​. IMO Ventures invests in startups that harness the power of computing and technology to drive change. They believe in supporting entrepreneurs from the ground up, providing not only financial backing but also strategic guidance and industry connections​. Their portfolio features a diverse range of companies, showcasing their commitment to fostering innovation across multiple sectors.

Impact America Fund (IAF) is a trailblazing venture capital firm dedicated to empowering marginalized communities through strategic investments in early-stage companies. Notable portfolio companies include Aja Labs, which innovates sustainable hair extension materials, and Mayvenn, a marketplace increasing income for independent hair stylists. Additionally, IAF has invested in Camino Financial, supporting Latinx-owned small businesses, and CareAcademy, which upskills home health caregivers. IAF focuses on industries that address systemic inequities, particularly within tech and consumer goods sectors, ensuring that economic participation and agency are accessible to people of color. Geographically, IAF targets the U.S., with a keen interest in underrepresented communities. The fund's strategy involves leading rounds and providing substantial support to its portfolio companies. With an average check size varying by stage, IAF is known for its hands-on approach, offering guidance beyond capital. The team prefers startups to approach them through their simple online form, emphasizing the importance of mission alignment. Founded by Kesha Cash, a seasoned investor with roots in both Wall Street and marginalized communities, IAF boasts a team with diverse expertise spanning tech, media, government, and law. Their latest $112 million fund aims to support 30 new companies, continuing their mission to uplift Black and Brown entrepreneurs and workers.

Impact Science Ventures is a venture capital firm based in San Francisco, California, focused on investing in scientific and technological innovations that address significant challenges in critical impact sectors, such as renewable energy, sustainability, and advanced materials. Founded in 2021, the firm emphasizes supporting early-stage companies that leverage breakthrough scientific research to create transformative solutions. The firm has a diverse portfolio, with investments spanning industries like alternative energy, energy infrastructure, and environmental services. Some of the notable companies in their portfolio include Antora Energy, known for its work in decarbonizing heavy industries, and Fervo Energy, which is pioneering next-generation geothermal energy solutions. Impact Science Ventures aims to be more than just a financial backer; they provide strategic support and resources to help these companies succeed commercially. Impact Science Ventures manages several funds, including their flagship Fund I, which is dedicated to early-stage investments. The firm is led by experienced professionals like Alain Harrus and Robert Ethier, who bring a wealth of knowledge in both venture capital and scientific research to their roles.

Impact46 is a leading venture capital firm based in Riyadh, Saudi Arabia, established in 2019. The firm focuses on early and growth-stage investments, particularly in the tech sector, and is one of the first VC firms to be authorized by Saudi Arabia's Capital Market Authority (CMA). Impact46 primarily invests in startups within Saudi Arabia but also targets promising opportunities across the MENA region. Key sectors include fintech, e-commerce, and SaaS. Their portfolio consists of notable startups like Jahez (a food delivery platform), Tamara (a buy-now-pay-later fintech company), and Syarah (an online automotive platform). Impact46’s investment in Jahez yielded a significant return, with the company going public in 2021 and offering a 22x return on investment. The firm’s strategy revolves around supporting local entrepreneurs with capital and strategic guidance to scale their businesses. They manage multiple funds, including a $133 million fund launched to continue supporting tech-driven startups across the region.

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.

Incite.org, founded by Swati Mylavarapu and Matt Rogers, is a unique hybrid organization that combines venture capital, philanthropy, and civic advocacy to drive positive global change. Their mission is to support bold, innovative entrepreneurs and activists who are working on underfunded and crucial challenges, particularly in areas like climate change, social justice, and economic opportunity. Incite operates through three primary branches: Incite Ventures, which provides catalytic capital to mission-driven startups with the potential to scale and make a significant impact; Incite Labs, a nonprofit arm that funds charitable and educational initiatives through grants and program-related investments; and Incite Politics, which supports political initiatives and candidates that aim to disrupt the status quo and promote diverse leadership. The team at Incite is deeply committed to fostering long-term relationships with the founders and organizations they support, offering not just funding but also mentorship, strategic advice, and access to a wide network of resources. Their investment philosophy focuses on finding and nurturing ideas that have the potential to create significant, lasting change. This approach has positioned Incite as a powerful force in impact investing, enabling them to back ventures that are not just profitable but also socially and environmentally responsible​.

Incubate Fund, established in 2010, is a leading early-stage venture capital firm based in Tokyo, Japan. The firm has a significant presence globally, with offices in key locations such as Singapore, Bangalore, Mumbai, São Paulo, and Mountain View. Known for its extensive portfolio, Incubate Fund has invested in over 300 companies and has facilitated numerous successful exits, including notable firms like Pixie Dust Technologies, Sansan, and WealthNavi. Incubate Fund Asia, a branch of the firm, recently announced the first close of its third fund with a target corpus of $50 million. This fund aims to support pre-seed and seed-stage startups across India and Southeast Asia, focusing on sectors such as B2B, B2C, supply chain, and consumer tech. Notable investments by Incubate Fund Asia include Captain Fresh, ShopKirana, and Yulu. The firm’s mission is to empower startups and fuel innovation across Asia. Incubate Fund provides financial support and strategic guidance to help startups achieve market leadership and sustainable growth

Indaco Venture Partners SGR, established in 2016, is Italy's largest independent venture capital firm, managing over €350 million across six funds. Their investment strategy is centered on breakthrough innovations, focusing primarily on sectors like electronics, robotics, medtech, biotech, pharma, and digital technologies. Indaco is renowned for supporting startups with cutting-edge proprietary technologies, typically participating in seed to Series B rounds with investments starting from €3 million. The firm's geographic reach spans Europe, the U.S., and Israel, but its core focus remains on Italian enterprises. Their anchor investors include leading institutions like Intesa Sanpaolo, Fondazione Cariplo, and the European Investment Fund, underscoring their credibility in the European VC landscape. Indaco has also forged strategic partnerships in digital and biotech sectors, such as with growITup and Università di Milano, allowing them to leverage deep industry expertise. Led by co-founders Davide Turco, Elizabeth Robinson, and Antonella Beltrame, the team has a wealth of experience in venture capital and has achieved numerous successful exits, including IPOs and major corporate transactions. Indaco's diverse team brings backgrounds from private equity, science, and technology research, giving them a unique ability to identify high-potential startups. For founders, Indaco’s rigorous selection process favors companies that can demonstrate technological leadership and scalability, especially those looking to expand globally. Their track record of over 40 portfolio companies and more than 15 successful exits makes them a key player in fostering the next generation of innovative leaders.